+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Intersect ENT Inc. - logo

Intersect ENT is a medical company that focuses on producing treatments for ears, nose and throat conditions through innovative research. It offers PROPEL and PROPEL mini drug releasing implants for patients undergoing sinus surgery to treat chronic sinusitis. They were formerly known as Sinexus, Inc. but changed their name to Intersect ENT in 2009. They were founded in 2003, and their headquarters are located in Menlo Park, California. They develop a pipeline of steroid releasing implants designed to provide ENT physicians with options to treat patients.

Sinus Dilation Devices - Global Strategic Business Report - Product Thumbnail Image

Sinus Dilation Devices - Global Strategic Business Report

  • Report
  • October 2024
  • 179 Pages
  • Global
From
Global Sinus Dilation Devices Market 2024-2028 - Product Thumbnail Image

Global Sinus Dilation Devices Market 2024-2028

  • Report
  • June 2024
  • 170 Pages
  • Global
From
From
Bronchoscope Global Market Report 2024 - Product Thumbnail Image

Bronchoscope Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Sinus Dilation Devices Global Market Report 2024 - Product Thumbnail Image

Sinus Dilation Devices Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
From
From
From
ENT Devices Global Market Report 2024 - Product Thumbnail Image

ENT Devices Global Market Report 2024

  • Report
  • November 2023
  • 400 Pages
  • Global
From
Global Sinus Dilation Devices Market Report and Forecast 2024-2032 - Product Thumbnail Image

Global Sinus Dilation Devices Market Report and Forecast 2024-2032

  • Report
  • September 2023
  • 160 Pages
  • Global
From
Loading Indicator